Home Online Features Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment
Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences’s Announcement of FDA IND Clearance for Friedreich’s Ataxia Treatment
Press Releases
GEMMA Biotherapeutics  
January 8, 2025

Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences’s Announcement of FDA IND Clearance for Friedreich’s Ataxia Treatment

PHILADELPHIA, Jan. 8, 2025 /PRNewswire/ -- Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics ("GEMMABio") commented on Solid Bioscience's announcement of clearance by the Food and Drug Administration

logo salamanca press

Salamanca Press

email salamanca press
Local & Social